skip to primary navigationskip to content
 

Life sciences equity crowdfunding platform, Capital Cell shortlisted for international award

last modified Jun 23, 2017 03:38 PM
Shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017

Today, ideaSpace West members, Capital Cell, Europe’s first equity crowdfunding platform specialised in life science, has been shortlisted for the prestigious Best International Growth Business award at the UK Business Angels Association Investment Awards 2017.

Capital Cell has been trading in Spain for just over 2 years, and has successfully closed 14 life science crowdfunding campaigns, including the country’s largest life science crowdfunding campaign of over 1.2M, for a potential therapeutic cure for MS.

Scaling-up from this Spanish platform, Capital Cell UK has just launched at www.capitalcell.co.uk, with a range of companies solving unmet needs from malaria control to female fertility enhancement and autoimmune disease.

In recognition of their contribution to the European life science ecosystem, the company has now been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017.

‘We are absolutely thrilled that Capital Cell has been recognised so early on in it’s expansion into the UK,’ says Laura Ferguson, UK Director. ‘The reception to our arrival has been overwhelmingly positive from players throughout the life science ecosystem, including specialised investors such as Angels in MedCity, with whom we are collaborating closely, as well as the NHS innovation, science parks and startup incubators. It’s wonderful to have that traction formally recognised’.

The UKBAA black-tie awards dinner will take place on July the 6th, at the Dorchester Hotel, London, with 300 leading innovators and investors assembled to celebrate the best of UK business.page1image17296page1image17456page1image17616

Capital Cell has already proven itself as a platform for early stage investment in a very challenging environment’, Chairman Ian Tomlinson adds, ‘so we are extremely excited about scaling up in the UK, which is a global leader not only in life science innovation but also in equity crowdfunding. As an investment area, life science has the potential for both huge social impact and significant financial returns and the companies listed on Capital Cell are all trying to solve a major unmet medical need. By opening up these investment opportunities to more people we hope to be able to help the UK remain at the cutting edge of life science commercialisation.'

About Capital Cell: 

Capital Cell was founded by Daniel Oliver, CEO, and has been trading in Spain for just over 2 years from their main operational office in Barcelona. Following investment into Capital Cell of more than 500k, including UK and Spanish business angels as well as “crowd” investment from their own 300kcrowdfunding campaign closed in March 2017, the company has now launched in the UK. Daniel Oliver remains in majority control of the company, with the UK launch being led alongside Laura Ferguson, UK Director.

Ian Tomlinson, UK Chairman (www.stevenagecatalyst.com/about/board_directors/ian_tomlinson/) was the co-founder of Domantis Ltd which was acquired by GSK for $454 million in 2006, and is also current Chairman of Stevenage BioScience Catalyst.

For more information, please contact:

Katie Anderton

Head of Marketing and Capital Cell

katie@capitalcell.net 

RSS Feed Latest news

Steve Marsh: 6 Ways to Grow Your Business

Aug 07, 2018

We met with Steve Marsh, Founder and CEO of GeoSpock; originally a student from Manchester who arrived in Cambridge to study his PhD, before developing his business idea into a flourishing reality

The Secrets to Simprints' Success

Jun 27, 2018

We met up with Simprints co-founder and CTO Tristram Norman to ask his advice on growing a business from 'a year of Sundays' project to a team of 25.

Mixcloud raises $11.5m from WndrCo

Apr 17, 2018

Audio streaming platform raises first ever funding round

FreeAgent Acquired by RBS in £53m Deal

Mar 28, 2018

Accounting software specialist FreeAgent has been bought by a subsidiary of Royal Bank of Scotland for £53 million.

Secure Thingz Acquired by IAR Systems

Mar 26, 2018

The future of security solutions for embedded systems

View all news